Ray Dalio Abbott Laboratories Transaction History

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Abbott Laboratories stock. As of the latest transaction made, Bridgewater Associates, LP holds 707,615 shares of ABT stock, worth $80.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

707,615

Previous 1,668,469 57.59%

Holding current value

$80.8 Million

Previous $173 Million 53.47%

% of portfolio

0.47%

Previous 0.92%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $96.2 Million - $114 Million	-960,854 Reduced 57.59%	707,615 $80.7 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $6.82 Million - $7.61 Million	-67,688 Reduced 3.9%	1,668,469 $173 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $17.6 Million - $19.5 Million	-161,062 Reduced 8.49%	1,736,157 $197 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $16 Million - $19.6 Million	-177,244 Reduced 8.54%	1,897,219 $209 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $24 Million - $28.8 Million	251,477 Added 13.79%	2,074,463 $201 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $33.8 Million - $37.7 Million	-335,716 Reduced 15.55%	1,822,986 $199 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $6.01 Million - $7.08 Million	-62,089 Reduced 2.8%	2,158,702 $219 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $81.7 Million - $95.8 Million	-859,163 Reduced 27.9%	2,220,791 $244 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $27.1 Million - $31.4 Million	280,041 Added 10.0%	3,079,954 $298 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $25.1 Million - $30.3 Million	-245,517 Reduced 8.06%	2,799,913 $304 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $98.2 Million - $120 Million	861,685 Added 39.46%	3,045,430 $360 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $36.2 Million - $44.3 Million	313,352 Added 16.75%	2,183,745 $307 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $8.58 Million - $9.49 Million	73,563 Added 4.09%	1,870,393 $221 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $74.9 Million - $88.2 Million	708,381 Added 65.08%	1,796,830 $208 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $19.1 Million - $22.5 Million	175,523 Added 19.23%	1,088,449 $130 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $50.3 Million - $54.9 Million	479,463 Added 110.61%	912,926 $100 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $39.7 Million - $48.2 Million	433,463 New	433,463 $47.2 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $4.18 Million - $5.35 Million	-54,586 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $3.43 Million - $5.01 Million	54,586 New	54,586 $4.31 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $409,202 - $438,093	-7,623 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $366,361 - $408,897	7,623	7,623 $407,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account